Strategic growth KJT Group is expanding capabilities with Sparq Intelligence featuring AI moderation and digital twin modeling, presenting opportunities to offer scalable decision-support and real-time evidence tooling to life sciences clients.

Executive leadership Recent high-level hires across research, medical and client strategy signal a bolstering of advisory and client delivery strength, creating openings to upsell advanced research solutions and integrated communications services.

Real-world evidenc With emphasis on real-world evidence and medical communications, there is potential to cross-sell end-to-end evidence generation, observational studies, and targeted dissemination to pharmaceutical and biotech customers.

DialogueDx leverag DialogueDx and generative AI capabilities offer a differentiator for deeper qualitative insights at scale, enabling you to pitch enhanced qualitative research and AI-assisted analytics to clients exploring patient and clinician conversations.

Financial scale Revenue in the mid seven figures and a mid-sized employee base indicate room to target mid-market life sciences brands and CROs seeking proven, cost-effective strategic research and communications partners.